TechTalk XL – Cell & Gene Therapies – Dutch Bio Science Week 2025

NecstGen is pleased to host the next edition of TechTalk XL during the Dutch Bio Science Week 2025 this summer. We invite you to join us for a focused afternoon of content and conversation on Cell & Gene Therapies.

TechTalk XL – Tuesday 1 July 2025

Hosted by NecstGen in collaboration with Leiden Bio Science Park

🗓 Date: Tuesday 1 July 2025
🕒 Time: 15:30 – 19:30
📍 Location: NecstGen, Mirai House | Sylviusweg 62, Leiden

NecstGen is pleased to host the next edition of TechTalk XL during the Dutch Bio Science Week 2025 this summer. We invite you to join us for a focused afternoon of content and conversation on Cell & Gene Therapies.

The TechTalk XL programme showcases speakers and brief snapshot talks that highlight innovative breakthroughs and share practical insights across the spectrum—from development to clinical translation—of advanced therapy medicinal products (ATMPs).

Programme:
15:30 – Arrival & Registration
16:00 – Speaker Session & Q&A

    • “Developing curative gene therapies for rare genetic diseases” by Frank Staal (Leiden University Medical Center)
    • “NTrans delivery platform – Unlocking next-generation T-cell therapies” by Ester Weijers (NTrans Technologies BV)
    • “Transforming the treatment landscape of Cancer & Autoimmune diseases with stem cell-derived Natural Killer cells” by Anna-Maria Georgoudaki (Glycostem Therapeutics)
    • “The Galapagos Decentralized Cell Therapy Manufacturing Platform” by Gemma Parsons (Galapagos)

 

17:00 – Snapshot Talks

Short, sharp insights from emerging voices in the field.

    • “Enabling end-to-end modular automation for organoid-based implants for regenerative medicine” by Isaak Decoene (KU Leuven)
    • “Automated, Decentralized Production for Advanced Therapies” by Julius Mathews (Fraunhofer IPT)
    • “Lighting Up Contamination: Accelerating Sterility Testing with ATP Bioluminescence” – Brice Meulah (biotactical)
    • “Safe Cells Start With Safe Donors: WMDA’s Mission to Protect the People Behind the Therapies” – Eefke van Eerden (WMDA)
    • “Cell and Gene Therapy Process Developement: Closing the Process” – Melissa van Pel (NecstGen)

From 17:30 – Networking
An opportunity to exchange ideas with peers, collaborators, and potential partners.

Last chance to sign up!
Attendance is free, but registration is required.


Please register in advance by clicking here

Get a glimpse of last years event here.

The First Stages of CAR T Cell Therapy Development

The First Stages of CAR T Cell Therapy Development

Chimeric Antigen Receptor (CAR) T cell therapy represents a transformative approach in medicine, particularly in oncology. This method offers personalised treatment by harnessing a patient's immune system to target and eliminate (cancer) cells. These novel therapies...

Webinar LV Process for CAR T

Webinar LV Process for CAR T

Shifting from traditional, ad hoc methodologies to a structured, data-based development approach to create a scalable, GMP-ready process.

NecstGen Services

Cell Therapy Development & Manufacturing

Viral Vector Development & Manufacturing

Cleanroom Rental

About Us

NecstGen is a non-profit CDMO and Centre of Excellence for Cell and Gene Therapy located in a purpose-built GMP facility in Leiden, The Netherlands. Dedicated to the field of Cell and Gene Therapies, we provide expertise and capacity.

NecstGen

Team

Partners

History

Facility

Ecosystem